Loading…
Congenital heart defects and maternal biomarkers of oxidative stress
BACKGROUND: Women who have had pregnancies that were affected by nonsyndromic congenital heart defects have alterations in the homocysteine-methionine pathway that may indicate increased exposure to oxidative stress or reduced antioxidant defense or both. OBJECTIVE: Our goal was to establish a mater...
Saved in:
Published in: | The American journal of clinical nutrition 2005-09, Vol.82 (3), p.598-604 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c438t-8ad272953a17b5fa617e22c7e264d2301387efd940889d68d1ffe745fa2ff6f03 |
---|---|
cites | cdi_FETCH-LOGICAL-c438t-8ad272953a17b5fa617e22c7e264d2301387efd940889d68d1ffe745fa2ff6f03 |
container_end_page | 604 |
container_issue | 3 |
container_start_page | 598 |
container_title | The American journal of clinical nutrition |
container_volume | 82 |
creator | Hobbs, Charlotte A Cleves, Mario A Zhao, Weizhi Melnyk, Stepan James, S Jill |
description | BACKGROUND: Women who have had pregnancies that were affected by nonsyndromic congenital heart defects have alterations in the homocysteine-methionine pathway that may indicate increased exposure to oxidative stress or reduced antioxidant defense or both. OBJECTIVE: Our goal was to establish a maternal metabolic risk profile for nonsyndromic congenital heart defects that would enhance current preventive strategies. DESIGN: Using a case-control design, we measured biomarkers of the transsulfuration pathway in a population-based sample of women whose pregnancies were affected by congenital heart defects (331 cases) and in a control group of women (125 controls). Plasma concentrations of reduced and oxidized glutathione, vitamin B-6, homocysteine, cysteine, cysteinylglycine (CysGly), and glutamylcysteine (GluCys) were compared between cases and controls after adjustment for lifestyle and sociodemographic variables. RESULTS: After covariate adjustment, cases had significantly lower mean plasma concentrations of reduced glutathione (P < 0.0001), GluCys (P < 0.0001), and vitamin B-6 (P = 0.0023) and significantly higher mean concentrations of homocysteine (P < 0.0001) and oxidized glutathione (P < 0.0001) than did controls. CONCLUSIONS: Biomarkers of oxidative stress involved in the transsulfuration pathway were significantly higher in women with pregnancies affected by congenital heart defects than in women without such a history. Further analysis of relevant biomarkers of oxidative stress and genetic and environmental factors is required to define the basis for the observed alterations. Identifying the nature and extent of alterations in biomarkers of oxidative stress may suggest primary intervention strategies and provide clues to a greater understanding of the pathogenesis of congenital heart defects. |
doi_str_mv | 10.1093/ajcn/82.3.598 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68568382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>898859691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-8ad272953a17b5fa617e22c7e264d2301387efd940889d68d1ffe745fa2ff6f03</originalsourceid><addsrcrecordid>eNpd0E1v1DAQBmALgehSOHJtIyS4ZWvPJI59rLYfIFXiAD1bs_G4zTYbFzuL4N_j1a5UicvMYR6N9L5CfFRyqaTFC9r004WBJS5ba16JhbJoagTZvRYLKSXUVun2RLzLeSOlgsbot-JEadW20OFCXK3i9MDTMNNYPTKlufIcuJ9zRZOvtjRzmsppPcQtpSdOuYqhin8GT_Pwm6s8J875vXgTaMz84bhPxf3N9c_V1_ru--231eVd3Tdo5tqQhw5si6S6dRtIq44B-jJ04wGlQtNx8LaRxlivjVchcNcUCSHoIPFUfDn8fU7x147z7LZD7nkcaeK4y06bVhs0UOCn_-Am7vZBsgNUtrGApqD6gPoUc04c3HMaSsq_Tkm379btu3UGHLrSbfFnx6e79Zb9iz6WWcDnI6Dc0xgSTf2QX1ynpEG5d-cHFyg6ekjF3P-AEl8qCS2iwn8UAIpq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>231949238</pqid></control><display><type>article</type><title>Congenital heart defects and maternal biomarkers of oxidative stress</title><source>ScienceDirect (Online service)</source><creator>Hobbs, Charlotte A ; Cleves, Mario A ; Zhao, Weizhi ; Melnyk, Stepan ; James, S Jill</creator><creatorcontrib>Hobbs, Charlotte A ; Cleves, Mario A ; Zhao, Weizhi ; Melnyk, Stepan ; James, S Jill</creatorcontrib><description>BACKGROUND: Women who have had pregnancies that were affected by nonsyndromic congenital heart defects have alterations in the homocysteine-methionine pathway that may indicate increased exposure to oxidative stress or reduced antioxidant defense or both. OBJECTIVE: Our goal was to establish a maternal metabolic risk profile for nonsyndromic congenital heart defects that would enhance current preventive strategies. DESIGN: Using a case-control design, we measured biomarkers of the transsulfuration pathway in a population-based sample of women whose pregnancies were affected by congenital heart defects (331 cases) and in a control group of women (125 controls). Plasma concentrations of reduced and oxidized glutathione, vitamin B-6, homocysteine, cysteine, cysteinylglycine (CysGly), and glutamylcysteine (GluCys) were compared between cases and controls after adjustment for lifestyle and sociodemographic variables. RESULTS: After covariate adjustment, cases had significantly lower mean plasma concentrations of reduced glutathione (P < 0.0001), GluCys (P < 0.0001), and vitamin B-6 (P = 0.0023) and significantly higher mean concentrations of homocysteine (P < 0.0001) and oxidized glutathione (P < 0.0001) than did controls. CONCLUSIONS: Biomarkers of oxidative stress involved in the transsulfuration pathway were significantly higher in women with pregnancies affected by congenital heart defects than in women without such a history. Further analysis of relevant biomarkers of oxidative stress and genetic and environmental factors is required to define the basis for the observed alterations. Identifying the nature and extent of alterations in biomarkers of oxidative stress may suggest primary intervention strategies and provide clues to a greater understanding of the pathogenesis of congenital heart defects.</description><identifier>ISSN: 0002-9165</identifier><identifier>EISSN: 1938-3207</identifier><identifier>DOI: 10.1093/ajcn/82.3.598</identifier><identifier>PMID: 16155273</identifier><identifier>CODEN: AJCNAC</identifier><language>eng</language><publisher>Bethesda, MD: American Society for Clinical Nutrition</publisher><subject>Adult ; Amino acids ; Arkansas ; Biological and medical sciences ; biomarkers ; Biomarkers - blood ; Birth defects ; Cardiology. Vascular system ; Case-Control Studies ; congenital abnormalities ; Congenital heart diseases. Malformations of the aorta, pulmonary vessels and vena cava ; cysteine ; Dipeptides - blood ; Female ; folic acid ; Folic Acid - blood ; glutathione ; Glutathione - blood ; Glutathione Disulfide - blood ; Heart ; Heart Defects, Congenital - blood ; Heart Defects, Congenital - etiology ; Heart Defects, Congenital - prevention & control ; homocysteine ; Homocysteine - blood ; Humans ; Infant, Newborn ; Life Style ; maternal effect ; maternal nutrition ; Medical sciences ; Mothers ; Oxidation ; oxidative stress ; Oxidative Stress - physiology ; Pregnancy ; pregnancy complications ; Pregnancy Complications - blood ; Pregnancy Complications - etiology ; Pregnancy Complications - prevention & control ; pyridoxine ; Registries ; Risk Factors ; S-Adenosylhomocysteine - blood ; Stress ; Vitamin B 6 - blood ; vitamin deficiencies</subject><ispartof>The American journal of clinical nutrition, 2005-09, Vol.82 (3), p.598-604</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright American Society for Clinical Nutrition, Inc. Sep 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-8ad272953a17b5fa617e22c7e264d2301387efd940889d68d1ffe745fa2ff6f03</citedby><cites>FETCH-LOGICAL-c438t-8ad272953a17b5fa617e22c7e264d2301387efd940889d68d1ffe745fa2ff6f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17108303$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16155273$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hobbs, Charlotte A</creatorcontrib><creatorcontrib>Cleves, Mario A</creatorcontrib><creatorcontrib>Zhao, Weizhi</creatorcontrib><creatorcontrib>Melnyk, Stepan</creatorcontrib><creatorcontrib>James, S Jill</creatorcontrib><title>Congenital heart defects and maternal biomarkers of oxidative stress</title><title>The American journal of clinical nutrition</title><addtitle>Am J Clin Nutr</addtitle><description>BACKGROUND: Women who have had pregnancies that were affected by nonsyndromic congenital heart defects have alterations in the homocysteine-methionine pathway that may indicate increased exposure to oxidative stress or reduced antioxidant defense or both. OBJECTIVE: Our goal was to establish a maternal metabolic risk profile for nonsyndromic congenital heart defects that would enhance current preventive strategies. DESIGN: Using a case-control design, we measured biomarkers of the transsulfuration pathway in a population-based sample of women whose pregnancies were affected by congenital heart defects (331 cases) and in a control group of women (125 controls). Plasma concentrations of reduced and oxidized glutathione, vitamin B-6, homocysteine, cysteine, cysteinylglycine (CysGly), and glutamylcysteine (GluCys) were compared between cases and controls after adjustment for lifestyle and sociodemographic variables. RESULTS: After covariate adjustment, cases had significantly lower mean plasma concentrations of reduced glutathione (P < 0.0001), GluCys (P < 0.0001), and vitamin B-6 (P = 0.0023) and significantly higher mean concentrations of homocysteine (P < 0.0001) and oxidized glutathione (P < 0.0001) than did controls. CONCLUSIONS: Biomarkers of oxidative stress involved in the transsulfuration pathway were significantly higher in women with pregnancies affected by congenital heart defects than in women without such a history. Further analysis of relevant biomarkers of oxidative stress and genetic and environmental factors is required to define the basis for the observed alterations. Identifying the nature and extent of alterations in biomarkers of oxidative stress may suggest primary intervention strategies and provide clues to a greater understanding of the pathogenesis of congenital heart defects.</description><subject>Adult</subject><subject>Amino acids</subject><subject>Arkansas</subject><subject>Biological and medical sciences</subject><subject>biomarkers</subject><subject>Biomarkers - blood</subject><subject>Birth defects</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>congenital abnormalities</subject><subject>Congenital heart diseases. Malformations of the aorta, pulmonary vessels and vena cava</subject><subject>cysteine</subject><subject>Dipeptides - blood</subject><subject>Female</subject><subject>folic acid</subject><subject>Folic Acid - blood</subject><subject>glutathione</subject><subject>Glutathione - blood</subject><subject>Glutathione Disulfide - blood</subject><subject>Heart</subject><subject>Heart Defects, Congenital - blood</subject><subject>Heart Defects, Congenital - etiology</subject><subject>Heart Defects, Congenital - prevention & control</subject><subject>homocysteine</subject><subject>Homocysteine - blood</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Life Style</subject><subject>maternal effect</subject><subject>maternal nutrition</subject><subject>Medical sciences</subject><subject>Mothers</subject><subject>Oxidation</subject><subject>oxidative stress</subject><subject>Oxidative Stress - physiology</subject><subject>Pregnancy</subject><subject>pregnancy complications</subject><subject>Pregnancy Complications - blood</subject><subject>Pregnancy Complications - etiology</subject><subject>Pregnancy Complications - prevention & control</subject><subject>pyridoxine</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>S-Adenosylhomocysteine - blood</subject><subject>Stress</subject><subject>Vitamin B 6 - blood</subject><subject>vitamin deficiencies</subject><issn>0002-9165</issn><issn>1938-3207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpd0E1v1DAQBmALgehSOHJtIyS4ZWvPJI59rLYfIFXiAD1bs_G4zTYbFzuL4N_j1a5UicvMYR6N9L5CfFRyqaTFC9r004WBJS5ba16JhbJoagTZvRYLKSXUVun2RLzLeSOlgsbot-JEadW20OFCXK3i9MDTMNNYPTKlufIcuJ9zRZOvtjRzmsppPcQtpSdOuYqhin8GT_Pwm6s8J875vXgTaMz84bhPxf3N9c_V1_ru--231eVd3Tdo5tqQhw5si6S6dRtIq44B-jJ04wGlQtNx8LaRxlivjVchcNcUCSHoIPFUfDn8fU7x147z7LZD7nkcaeK4y06bVhs0UOCn_-Am7vZBsgNUtrGApqD6gPoUc04c3HMaSsq_Tkm379btu3UGHLrSbfFnx6e79Zb9iz6WWcDnI6Dc0xgSTf2QX1ynpEG5d-cHFyg6ekjF3P-AEl8qCS2iwn8UAIpq</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Hobbs, Charlotte A</creator><creator>Cleves, Mario A</creator><creator>Zhao, Weizhi</creator><creator>Melnyk, Stepan</creator><creator>James, S Jill</creator><general>American Society for Clinical Nutrition</general><general>American Society for Clinical Nutrition, Inc</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T7</scope><scope>7TS</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>Congenital heart defects and maternal biomarkers of oxidative stress</title><author>Hobbs, Charlotte A ; Cleves, Mario A ; Zhao, Weizhi ; Melnyk, Stepan ; James, S Jill</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-8ad272953a17b5fa617e22c7e264d2301387efd940889d68d1ffe745fa2ff6f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Amino acids</topic><topic>Arkansas</topic><topic>Biological and medical sciences</topic><topic>biomarkers</topic><topic>Biomarkers - blood</topic><topic>Birth defects</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>congenital abnormalities</topic><topic>Congenital heart diseases. Malformations of the aorta, pulmonary vessels and vena cava</topic><topic>cysteine</topic><topic>Dipeptides - blood</topic><topic>Female</topic><topic>folic acid</topic><topic>Folic Acid - blood</topic><topic>glutathione</topic><topic>Glutathione - blood</topic><topic>Glutathione Disulfide - blood</topic><topic>Heart</topic><topic>Heart Defects, Congenital - blood</topic><topic>Heart Defects, Congenital - etiology</topic><topic>Heart Defects, Congenital - prevention & control</topic><topic>homocysteine</topic><topic>Homocysteine - blood</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Life Style</topic><topic>maternal effect</topic><topic>maternal nutrition</topic><topic>Medical sciences</topic><topic>Mothers</topic><topic>Oxidation</topic><topic>oxidative stress</topic><topic>Oxidative Stress - physiology</topic><topic>Pregnancy</topic><topic>pregnancy complications</topic><topic>Pregnancy Complications - blood</topic><topic>Pregnancy Complications - etiology</topic><topic>Pregnancy Complications - prevention & control</topic><topic>pyridoxine</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>S-Adenosylhomocysteine - blood</topic><topic>Stress</topic><topic>Vitamin B 6 - blood</topic><topic>vitamin deficiencies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hobbs, Charlotte A</creatorcontrib><creatorcontrib>Cleves, Mario A</creatorcontrib><creatorcontrib>Zhao, Weizhi</creatorcontrib><creatorcontrib>Melnyk, Stepan</creatorcontrib><creatorcontrib>James, S Jill</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of clinical nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hobbs, Charlotte A</au><au>Cleves, Mario A</au><au>Zhao, Weizhi</au><au>Melnyk, Stepan</au><au>James, S Jill</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital heart defects and maternal biomarkers of oxidative stress</atitle><jtitle>The American journal of clinical nutrition</jtitle><addtitle>Am J Clin Nutr</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>82</volume><issue>3</issue><spage>598</spage><epage>604</epage><pages>598-604</pages><issn>0002-9165</issn><eissn>1938-3207</eissn><coden>AJCNAC</coden><abstract>BACKGROUND: Women who have had pregnancies that were affected by nonsyndromic congenital heart defects have alterations in the homocysteine-methionine pathway that may indicate increased exposure to oxidative stress or reduced antioxidant defense or both. OBJECTIVE: Our goal was to establish a maternal metabolic risk profile for nonsyndromic congenital heart defects that would enhance current preventive strategies. DESIGN: Using a case-control design, we measured biomarkers of the transsulfuration pathway in a population-based sample of women whose pregnancies were affected by congenital heart defects (331 cases) and in a control group of women (125 controls). Plasma concentrations of reduced and oxidized glutathione, vitamin B-6, homocysteine, cysteine, cysteinylglycine (CysGly), and glutamylcysteine (GluCys) were compared between cases and controls after adjustment for lifestyle and sociodemographic variables. RESULTS: After covariate adjustment, cases had significantly lower mean plasma concentrations of reduced glutathione (P < 0.0001), GluCys (P < 0.0001), and vitamin B-6 (P = 0.0023) and significantly higher mean concentrations of homocysteine (P < 0.0001) and oxidized glutathione (P < 0.0001) than did controls. CONCLUSIONS: Biomarkers of oxidative stress involved in the transsulfuration pathway were significantly higher in women with pregnancies affected by congenital heart defects than in women without such a history. Further analysis of relevant biomarkers of oxidative stress and genetic and environmental factors is required to define the basis for the observed alterations. Identifying the nature and extent of alterations in biomarkers of oxidative stress may suggest primary intervention strategies and provide clues to a greater understanding of the pathogenesis of congenital heart defects.</abstract><cop>Bethesda, MD</cop><pub>American Society for Clinical Nutrition</pub><pmid>16155273</pmid><doi>10.1093/ajcn/82.3.598</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9165 |
ispartof | The American journal of clinical nutrition, 2005-09, Vol.82 (3), p.598-604 |
issn | 0002-9165 1938-3207 |
language | eng |
recordid | cdi_proquest_miscellaneous_68568382 |
source | ScienceDirect (Online service) |
subjects | Adult Amino acids Arkansas Biological and medical sciences biomarkers Biomarkers - blood Birth defects Cardiology. Vascular system Case-Control Studies congenital abnormalities Congenital heart diseases. Malformations of the aorta, pulmonary vessels and vena cava cysteine Dipeptides - blood Female folic acid Folic Acid - blood glutathione Glutathione - blood Glutathione Disulfide - blood Heart Heart Defects, Congenital - blood Heart Defects, Congenital - etiology Heart Defects, Congenital - prevention & control homocysteine Homocysteine - blood Humans Infant, Newborn Life Style maternal effect maternal nutrition Medical sciences Mothers Oxidation oxidative stress Oxidative Stress - physiology Pregnancy pregnancy complications Pregnancy Complications - blood Pregnancy Complications - etiology Pregnancy Complications - prevention & control pyridoxine Registries Risk Factors S-Adenosylhomocysteine - blood Stress Vitamin B 6 - blood vitamin deficiencies |
title | Congenital heart defects and maternal biomarkers of oxidative stress |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A31%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20heart%20defects%20and%20maternal%20biomarkers%20of%20oxidative%20stress&rft.jtitle=The%20American%20journal%20of%20clinical%20nutrition&rft.au=Hobbs,%20Charlotte%20A&rft.date=2005-09-01&rft.volume=82&rft.issue=3&rft.spage=598&rft.epage=604&rft.pages=598-604&rft.issn=0002-9165&rft.eissn=1938-3207&rft.coden=AJCNAC&rft_id=info:doi/10.1093/ajcn/82.3.598&rft_dat=%3Cproquest_cross%3E898859691%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c438t-8ad272953a17b5fa617e22c7e264d2301387efd940889d68d1ffe745fa2ff6f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=231949238&rft_id=info:pmid/16155273&rfr_iscdi=true |